baber/WOPTO huggingface dataset:
Patent NZ-514028-A (NZ)
Title: Dispensing razor blade cartridges used with a handle
Inventor: METCALF STEPHEN C
IPC: B26B21/52
Filed: 1998-02-18
Abstract: A cartridge for razor blade cartridges used with a handle comprising a housing structure defining sections for receiving respective cartridges.  The house structure including a base (34), side walls, and a plurality of cartridge dividers between the sections, the cartridge dividers including angled dividers (42) having upper and lower surfaces (44) that make acute angles with said base and define angled regions for receiving the cartridges.  The angled regions being partially bounded by an upper surface of one angled divider and a facing lower surface of an adjacent angled divider, the angled dividers having upper surfaces for extending above uppermost regions of the cartridges when said cartridges are received in the sections.
Patent NZ-515226-A (NZ)
Title: Anionic polymers useful as toxin binders and antibacterial agents
Inventor: KURTZ CAROLINE
IPC: A61P31/04
Filed: 2000-05-11
Abstract: A  polymer  or a salt thereof with a  pharmaceutically acceptable   cation  is  used  in  the  manufacture   of   a medicament  for  inhibiting a bacterial,  fungal,  protozoal pathogenic  toxin  in  a  patient.   The  polymer  comprises pendant  acid  functional groups connected  to  the  polymer backbone  by  aliphatic or aromatic  spacer  groups  and  is substantially free of acid anhydride groups.
Patent NZ-516293-A (NZ)
Title: Herbicidal compositions containing surfactants of alkyl and/or alkenyl amido amine oxides
Inventor: MILLE FABIEN HERVE JOSEPH
IPC: A01N25/30
Filed: 2000-07-28
Abstract: A herbicidal solution concentrate comprising from 30% by weight to saturation of a water soluble glyphosate salt and from 8 to 20% by weight of surfactant comprising 10 to 100% by weight based on the total weight of surfactant of an alkyl and/or alkenyl amido amine oxide of the formula, where: R is a C6-20 alkyl or alkenyl group; m is 1 to 4; p and q are independently 0 to 3; and from 0 to 90% by weight based on the total weight of surfactant of ether carboxylate.
Patent NZ-517673-A (NZ)
Title: Chemically-stabilized chlorite solutions for treating cancer and other diseases
Inventor: KUHNE FREDERICH
IPC: A61K33/20
Filed: 2000-08-18
Abstract: Methods of using a stabilized chlorite matrix to modulate immune responses and treat cancer are disclosed. The stabilized chlorite matrix, when administered to a mammal in need thereof, can activate immune cells in a manner similar to interferon gamma but does not effect the production of inflammatory and shock related cytokines like tumor necrosis alpha. The stabilized chlorite matrix also upregulates the expression of the DCC protein in macrophages, a protein whose expression is related to neoplastic transformation. By activating macrophages, the stabilized chlorite matrix therefore is useful as an immunomodulatory agent and in treating cancer.
Patent NZ-522851-A (NZ)
Title: Treatment of inflammatory diseases associated with neutrophil or eosinophil granulocyt inflitration with EPO optionally with alpha-MSH
Inventor: NIELSEN SOREN
IPC: A61P21/00
Filed: 2001-05-02
Abstract: EPO or an EPO equivalent optionally in combination with alpha-MSH (melancortin stimulating hormone) or an alpha-MSH equivalent are used in the manufacture of a medicament for treatment or prevention of an inflammatory condition under non-ischemic conditions in airways and lungs or in the kidneys or in the urinary tract. Also disclosed is a pharmaceutical composition comprising a unit dosage of EPO and a unit dosage of alpha-MSH together with a suitable pharmaceutical carrier, in which the alpha-MSH is present in an amount which enhances the effect of EPO.
Patent NZ-529584-A (NZ)
Title: Zinc finger binding domains for GNG
Inventor: BARBAS CARLOS F
IPC: C12Q1/6897
Filed: 1999-10-14
Abstract: Zinc finger-nucleotide binding Polypeptides having binding specificity for target nucleotides containing one or more GNN triplets are provided. Compositions containing such polypeptides and the use of such polypeptides and compositions for regulating nucleotide function are also provided.
Patent NZ-532062-A (NZ)
Title: 2-propynyl adenosine analogues having A2 adenosine recepter agonist activity and compositions thereof to treat inflammatory responses
Inventor: LINDEN JOEL M
IPC: A61K31/4015
Filed: 2002-10-01
Abstract: Compounds having general formula (I) are described, wherein Z is CR3R4R5 or NR4R5; each R7 is independently hydrogen, (C1-C8)alkyl, (C3-C8)cycloalkyl, aryl or aryl (C1-C8)alkylene, heteroaryl, heteroaryl (C1-C8)alkylene- ; Xis-CH2ORa, -CO2Ra,- OC(O)Ra, -CH2OC(O)Ra, -C(O)NRaRb, -CH2SRa, -C(S)ORa, -OC(S)Ra, -CH2OC(S)Ra or C(S)NRaRb or -CH2N(Ra)(Rb) R1 and R2 and the atom to which they are attached is C=O, C=S or C=NRc. Rc is hydrogen or (Cl-C8)-alkyl ; m is 0 to about 8 and p is 0 to 2 ; provided that m is at least 1 when Z is NR4R5 ; or a pharmaceutically acceptable salt thereof. Also described are compounds of general formula (I) and methods of their use for the treatment of inflammatory activity in mammalian tissue. The inflammatory tissue activity can be due to pathological agents or can be due to physical, chemical or thermal trauma, or the trauma of medical procedures, such as organ, tissue or cell transplantation, angioplasty (PCTA), inflammation following ischemia/reperfusion, or grafting. The present compounds comprise a class of 2-alkynyladenosine derivatives, substituted at the ethyn-2-yl position by substituted cycloalkyl and heterocycle (heterocyclic) moieties.
Patent NZ-535587-A (NZ)
Title: Localized fluid delivery having a porous applicator and methods for using the same
Inventor: RIEBMAN JEROME B
IPC: A61M1/00
Filed: 2003-02-25
Abstract: Fluid delivery devices having a porous applicator, as well as methods for using the same in the highly localized delivery of fluid to a target site, are provided. The subject devices have a porous applicator through which fluid must flow in order to contact the target delivery site. The subject devices find use in a variety of fluid delivery applications in which the localized delivery of a fluid to a target site is desired. Also provided are systems and kits that include the subject fluid delivery devices.
Patent NZ-535656-A (NZ)
Title: Process and intermediates for preparing a cyclohexylnitrile
Inventor: WEBB KEVIN SCOTT
Filed: 2001-01-12
Abstract: A method for preparing a a,b-unsaturated cyclohexene carboxylic acid of formula (A) is disclosed, wherein the method comprises hydrolysing the a,b-unsaturated cyclohexene dicarbonitrile of formula (B), wherein the hydrolysis is carried out using thionyl chloride, where Ar is an aromatic group.
Patent NZ-535982-A (NZ)
Title: Modulators that can either accelerate or retard the damage of cells, such as skin cells, caused by exposure to light
Inventor: WONDRAK GEORG T
IPC: A61K31/4015
Filed: 2003-04-17
Abstract: Described is the use of an amount of a photodamage modulator sufficient to modulate photodamage caused by ultraviolet light for the manufacture of a medicament for modulating photodamage in a subject, wherein (i) the modulator enhances photodamage and has a structure comprising a 3-hydroxypyridine pharmacophore, or is collagen derived, or (ii) the modulator inhibits photodamage and is proline, 4- hydroxyproline, or an alkyl ester thereof.
Patent NZ-538925-A (NZ)
Title: Blocking device for a sprung lock with a spring operation
Inventor: SCHYRA MICHAEL
Filed: 2003-08-23
Abstract: The useful life of a device needs to be limited, where hygienic, medical or technical grounds exist. A device which cannot be influenced by the user is thus required, which reliably, effectively and terminally prevents the further use of the device, as soon as the given number of operations is achieved. A locking device with spring operation and a counter is provided on the device and housed in a two-piece housing, the both parts of which are mounted such as to rotate relative to each other and the above can be blocked by a pre-tensioned leaf spring. The leaf spring is originally housed in a recess in the wall of the one housing piece. As soon as the permitted number of operations is achieved, a pin extends the leaf spring from the rest position thereof. The leaf spring then extends into a recess in the wall of the other housing piece such that the both housing pieces can no longer be rotated relative to each other. The pin can be located within the display of the counter. The blocking device can only be overcome with a force great enough to destroy the device. The device is suitable for blocking a high-pressure nebuliser or a needleless injector, by means of which a fluid is atomised to give an aerosol or a fluid is injected into a biological tissue.
Patent NZ-539566-A (NZ)
Title: Semiconductor emitter/detector optical device formed as resonant cavity light emitting device, typically for analysis of biological samples
Inventor: SUMMERS HUW DAVID
IPC: H01L31/0232
Filed: 2003-10-22
Abstract: A semiconductor optical device being a resonant cavity device in this form of an LED comprises a single substrate arranged for emitting light (O) for incidence on a sample or other element and also responsive to light (D), e.g. of a different wavelength, received back from this sample or other element: the device further comprises means for monitoring a characteristic (e.g. its current-voltage characteristic) which varies in dependence upon the light (D) received back from the sample or other element.
Patent NZ-542501-A (NZ)
Title: Compositions comprising chitin or chitosan and use thereof
Inventor: VOURNAKIS JOHN N
IPC: A61K35/16
Filed: 2004-02-24
Abstract: Disclosed is a composition produced ex vivo comprising (i) platelets, (ii) poly-beta-1->4-N-acetylglucosamine fibers, and (iii) a calcium salt or a calcium salt solution. The composition is useful for preserving platelets or producing a gel composition comprising platelets which is useful for promoting wound healing.
Patent NZ-545047-A (NZ)
Title: Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
Inventor: HAMMOND H
IPC: A61K35/76
Filed: 1999-02-09
Abstract: Provided is the use of a vector in the manufacture of a medicament for use in the treatment of cardiovascular disease in a patient, wherein said medicament is formulated for intra-arterial injection coincident with or after infusion of the artery with a vasoactive agent selected from histamine or a histamine agonist and wherein the vector comprises a transgene encoding a protein to be expressed in the vascular bed of a tissue or organ supplied by the artery. Further provided are similar uses with specified vasoactive agents (e.g. histamine or histamine agonist) and gene vectors coding for specified genes, e.g. aFGF or VEGF.
Patent NZ-547874-A (NZ)
Title: Method of shrinking a film by applying heat and radiation
Inventor: GRAH MICHAEL D
IPC: B32B27/20
Filed: 2004-12-29
Abstract: This discloses a method of shrinking a film 20. The film comprises one or more thermoplastic polymers 22 24 and at least about 0.001 weight % of single-walled carbon nanotube material 16 based on the weight of the film 20, and has a free shrink at 185°F in at least one of the machine or transverse directions of at least about 5% measured according to ASTM D 2732. The shrinkage is done by exposing the film 20 to an amount of radiation energy effective to activate the shrink characteristic of the film 20.
Patent NZ-548296-A (NZ)
Title: Production of hop extracts having oestrogenic and antiproliferative bioactivity
Inventor: DE KEUKELEIRE DENIS
IPC: A61P5/24
Filed: 2004-12-15
Abstract: Provided is a method for the production of a hop extract which is enriched in 8-prenylnaringenin with respect to 6-prenylnaringenin, wherein the method comprises the steps of subjecting hops or a hop product to (1) an isomerisation reaction in the presence of water as a solvent and in the presence of an amount of a base and (2) to at least one extraction. Further provided are hop extracts produced by the method and their use in the manufacture of medicaments.
Patent NZ-548932-A (NZ)
Title: Intermediates and processes using them for preparing moxidectin
Inventor: CULLEN THOMAS GERARD
Filed: 2006-08-04
Abstract: Disclosed herein is a compound of formula (I) and the use thereof in the preparation of moxidectin, wherein the variables shown in formula (I) are as defined in the specification.
Patent NZ-548974-A (NZ)
Title: Pressure sensor apparatus for non-invasively measuring hemodynamic parameters
Inventor: HESSEL STEPHEN R
Filed: 2003-10-10
Abstract: Pressure sensor apparatus, adapted for tonometrically measuring the blood pressure of a living subject, includes a pressure sensor adapted to generate an electrical signal relating to the pressure applied to at least one surface. A housing element at least partly receives said sensor therein and a coupling adapter couples said sensor apparatus to an actuator apparatus. A support element flexibly retains said pressure sensor apparatus at least when said coupling adapter is decoupled from said actuator apparatus, and a coupling medium couples pressure waves on the skin of a subject to said at least one surface.
Patent NZ-549048-A (NZ)
Title: Carcinoembryonic antigen fusion proteins and uses thereof
Inventor: LA MONICA NICOLA
IPC: A61K39/00
Filed: 2005-02-03
Abstract: Disclosed is a nucleic acid molecule comprising a sequence of nucleotides that encodes a CEA fusion protein, wherein the CEA fusion protein comprises a CEA protein or a functional variant, fused to a subunit B of heat labile enterotoxin of E. coli (LTB) or a functional variant; wherein said CEA protein comprises a sequence of amino acids as set forth in SEQ ID NO: 18, 19, or 20, and wherein the fusion protein is capable of producing an immune response in a mammal.
Patent NZ-549494-A (NZ)
Title: Benzopyran compound useful for the treatment of arrhythmia
Inventor: TSUKAGHOSHI TORU
IPC: A61K31/353
Filed: 2005-02-25
Abstract: Disclosed is a benzopyran derivative of formula (I), or a pharmaceutically acceptable salt thereof, wherein Y is a bond, SO, or SO2, Z is C1-4alkyl optionally substituted with 1-5 halogen atoms, R1 and R2 are optionally substituted C1-3alkyl, R3 is H, OH, or OMe, R6 is H or C1-4alkyl, m is 0-4, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound to treat arrhythmia.
Patent NZ-550098-A (NZ)
Title: Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
Inventor: JANSSENS FRANS EDUARD
IPC: A61K31/495
Filed: 2005-04-04
Abstract: Disclosed are compounds of general formula (I) wherein the substituents are as described in the specification. Compounds of formula (I) have neurokinin (NK1 and NK1/NK3) antagonistic activity, and are useful in the treatment of schizophrenia, emesis, anxiety and depression, irritable bowl syndrome, circadian rhythm disturbances, pre-eclampsia, nociception, pain, pancreatitis, neurogenic inflammation, asthma, chronic obstructive pulmonary disease and urinary incontinence.
Patent NZ-552030-A (NZ)
Title: Multi-layer tablet comprising non-steroidal anti-inflammatory drugs decongestants and non-sedating antihistamines
Inventor: BERLIN ROGER
IPC: A61K31/137
Filed: 2005-06-01
Abstract: Disclosed is a pharmaceutical composition comprising an effective amount of each of (a) a non-steroidal anti-inflammatory drug (NSAID), (b) a decongestant; and (c) an antihistamine, wherein the composition is a multi-layer tablet; at least one of the NSAID, the decongestant and the antihistamine is in each layer of the multi-layer tablet ; each of the NSAID, the decongestant and the antihistamine is in only one layer of the multilayer tablet; and optionally the multilayer tablet is surrounded by a coating. A method of preparing a pharmaceutical composition is also disclosed, wherein the method comprises: (a) selecting a non-steroidal anti-inflammatory drug (NSAID), a decongestant, and an antihistamine; (b) determining the duration profile of each of the NSAID, the decongestant and the antihistamine; (c) preparing at least one immediate release matrix comprising at least one of the NSAID, the decongestant and the antihistamine; (d) preparing at least one extended release matrix comprising at least one of the NSAID, the decongestant and the antihistamine and wherein the at least one of the NSAID, the decongestant and the antihistamine has been modified to extend the release profile; and (e) forming the at least one immediate release matrix and the at least one extended release matrix into a layered solid dosage form.
Patent NZ-554319-A (NZ)
Title: Wall mounted appliance apparatus where the appliance swings out horizontally to become perpendicular to the wall
Inventor: SALMON RUSSELL
IPC: A47J47/16
Filed: 2005-09-02
Abstract: A wall mounted appliance apparatus (10) is disclosed. Using the apparatus an appliance (11) is able to be positioned inside a wall to save space but swung out of the wall to be operated. The apparatus (10) includes an appliance support (21) for supporting the appliance (11), a housing (13) arranged for mounting to a wall and a mounting means (16) between the housing (13) and the appliance support (21). The mounting means (16) is interposed between the housing (13) and the appliance support (21) for mounting the appliance support (21) to the housing (13). The mounting means (16) includes two pairs of mounting struts (14,15). The mounting means (16) permits movement of the appliance support (21) between a closed position and an open position. In the closed position the appliance support (21) is substantially parallel to or coplanar with the wall. In the open attitude the appliance support (21) is pivoted away from the wall a distance sufficient to operate the appliance (11). The locus of the appliance support in its movement between the closed and the open positions is such that, taken from the closed attitude, for a first portion of the locus, the appliance support (12) moves substantially normal to the plane of the wall, remaining substantially parallel thereto, and for a second portion of the locus, the appliance support (21) pivots about an axis substantially parallel to the wall such that the plane of the appliance support (21) is oblique to the plane of the wall.
Patent NZ-556318-A (NZ)
Title: N-(heteroaryl)-1H-indole-2-carboxamide derivatives and their use as vanilloid TRPV1 receptor ligands
Inventor: DUBOIS LAURENT
IPC: A61K31/33
Filed: 2006-01-04
Abstract: Disclosed are N-(heteroaryl)-1H-indole-2-carboxamide-based compounds of formula (I) wherein W is a fused bicyclic group and the remaining substituents are as defined in the specification, a process for preparing compounds of formula (I) and their agonist or antagonist effects on the TRPV1 receptor. Also disclosed is their use in treating diseases such as pain and inflammation, urological disorders, gynaecological disorders, gastrointestinal disorders, respiratory disorders, psoriasis, pruritus, dermal, ocular or mucous irritation, herpes and zona.
Patent NZ-556324-A (NZ)
Title: Device for forcing apart spinous processes
Inventor: KLOSS HENNING
IPC: A61B17/02
Filed: 2006-02-08
Abstract: The disclosure relates to a device for forcing apart the spinous processes of two successive vertebrae. The spinous processes of the two vertebrae are placed on two separate widening means which are fixed to a base body that can be continuously widened. The base body can be continuously displaced and fixed by at least one guiding means. The separate displacement of the base body enables the widening means to be widened along the axial axis, thus forcing apart the spinous processes of the two vertebrae. Holding means can be used for a stable positioning of the implant and prevent an undesired movement of the device after the implantation.
Patent NZ-565293-A (NZ)
Title: Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof
Inventor: FRICK WENDELIN
IPC: C07D281/10
Filed: 2006-07-13
Abstract: The disclosure relates to a compound of formula (A) and the physiologically acceptable salts thereof suitable as a hypolipidemic agent, for example.
Patent NZ-567057-A (NZ)
Title: Tissue disruption treatment and composition for use thereof
Inventor: EDWARDS JEFFREY D
IPC: A61K33/242
Filed: 2006-09-01
Abstract: Disclosed is a composition of denatured plasma protein; at least one metal, metal ion or metal salt; and a pharmaceutically-acceptable carrier. The denatured plasma protein is produced by heating the plasma to about 80 degrees Celsius with sodium bicarbonate and then separating the denatured plasma protein from non-denatured plasma. The denatured plasma protein is then mixed with at least one metal, metal ion or metal salt; and heated to at least 50 degrees Celsius to produce a mixture to which a pharmaceutically-acceptable carrier is then added. The composition is capable of: a) healing tissue disruptions; and/or b) modulating apoptosis; and/or c) modulating the activity of TNF-alpha; and/or d) modulating the activity of TNF-alpha receptor; and/or e) modulating the activity of TACE; and/or f) modulating the activity of a caspase, especially caspase-1, caspase-3 and/or caspase-9 The method for preparing the composition is also disclosed. The metals in particular are selected from nickel, sodium, copper, zinc, cobalt, iron, magnesium, manganese, potassium, silver and mercury. The use of the composition in a medicament to treat lesions, wounds, microbial infections, burns, ulcers, soft tissue injuries, connective tissue injuries, inflammation and dermal conditions, especially sunburn, is also disclosed.
Patent NZ-569679-A (NZ)
Title: Fencing system and tensioner that applies more tension when reeling-in than dispensing
Inventor: REID PAUL CLIFFORD
IPC: B65H54/02
Filed: 2008-07-07
Abstract: A (14) tensioner for a fencing wire reel. When the wire is reeled in or out, the tensioner (14) pushes against the wire, making it tense. The tensioner (14) pushes harder when the wire is being reeled in than when it is dispensed. The tensioner (14,15) includes a housing (21) connected to a spring (28) by a hinge (24). When the wire is dispensed the spring (28) pivots away from the housing (21), letting the wire pass with less tension.
Patent NZ-573614-A (NZ)
Title: Processes for making caralluma extracts and uses
Inventor: RAJENDRAN RAMASWAMY
IPC: A23L33/00
Filed: 2004-05-31
Abstract: Provided is a synergistic pharmaceutical, medicinal or nutraceutical composition comprising an extract of plant matter from one or more Caralluma species, wherein said extract comprises at least two pregnane glycosides including at least one caratuberside including the isomers and pharmaceutically acceptable salts thereof and at least one bouceroside including the isomers and pharmaceutically acceptable salts thereof and wherein the extract is substantially free of resin. The compositions are useful in the treatment of obesity and obesity-related disorders. (62) Divided Out of 543995
Patent NZ-578562-A (NZ)
Title: Pesticidal mixtures comprising fipronil or ethiprole and prochloraz
Inventor: VOESTE DIRK
IPC: A01N43/40
Filed: 2008-02-05
Abstract: Disclosed is a pesticidal mixture comprising: 1.) An insecticidal comound selected from fipronil and ethiprole; and 2.) A fungicidal compound selected from prochloraz. Also disclosed is said mixture additionally comprising one or two fungicidal compounds selected from an azole, a strobilurin, a carboximide, a heterocyclic compound (e.g., fluzinam), a carbamate, and other active compounds such as guanidines, aluminium, triticonazole and mancozeb in synergistically effective amounts. Further disclosed is a pesticidal composition comprising a liquid or solid carrier and said mixture, and a method for controlling harmful fungi and insects comprising contacting with said mixture.